Today’s top gainers include the company Perrigo Company plc (NYSE:PRGO) which is in the industry Drug Related Products, gaining -2.80% today. In the last week its performance is -0.67%, and -26.14% for the past quarter. Currently, Perrigo Company plc, PRGO has a target price of 118.69, so today’s gain of -2.80% is a significant step towards its target price. The GAP today is therefore 0.24%.
Perrigo Company plc (NYSE:PRGO), has a market cap of 13430.76, and is based in Ireland. Insider ownership is at 0.20%, and institutional ownership is 79.60%.
At the current price of 92.19, it has a dividend yield of 0.61%, and its target price is 118.69. This is with a profit margin of -3.80%, and total debt/equity of 0.66. Perrigo Company plc (NYSE:PRGO) has a P/E of *TBA, as well as a forward P/E of 10.43.
With a current EPS of -1.91, and a forecasted EPS growth for next year at 10.43%,Perrigo Company plc (NYSE:PRGO) has had a EPS growth for the past five years at -59.80%. For the next five years EPS growth is projected to be 7.99%.
Performance for the year is -49.08%. Since its IPO date on 12/17/1991, the total performance to date is -34.28%.
Volume today for Perrigo Company plc (NYSE:PRGO), is 983818, while its average volume is 3105.24. Whilst the total gain today was -2.80%, it did have a day high of -16.95%.
Volatility for this week has been at 2.76%, and 2.55% for the month. The 52-week low for Perrigo Company plc, PRGO has been 8.81%, while the 52-week-high has reached -53.34%.
Looking at its return of investments, which is 0.80%, and its return on assets is -1.10%. Perrigo Company plc (NYSE:PRGO) has an operating margin of -0.40%. With a sales growth of 31.80% quarter over quarter. Bearing in mind that Perrigo Company plc, PRGO is in the sector Healthcare, its long-term debt/equity is 0.6, and has a current ratio of 1.4 and 1 for quick ratio.
So what is the value of Perrigo Company plc? Well its PEG is *TBA, and the P/S is 2.36, along with a P/B of 1.38. Meanwhile it has a p/cash of *TBA.